Sermorelin and ipamorelin: what is in it and does it work?

What is in the sermorelin and ipamorelin blend?

Sermorelin and ipamorelin contains Sermorelin and Ipamorelin. Sold as a premixed vial or as two vials, in amounts that vary by seller. Some licensed programs prescribe compounded sermorelin on its own; the ipamorelin component has no lawful source. PeptideAgent does not name or link sellers.

Also searched as: Sermorelin ipamorelin; Sermorelin/ipamorelin blend; Sermorelin and ipamorelin blend.

Grades and statuses come from each peptide's own record and update with it. Grades follow the methodology.

Why are these peptides combined in the sermorelin and ipamorelin blend?

The pairing uses the same logic as other GHRH and ghrelin mimetic combinations: stimulate growth hormone through both release pathways. A 1990 study in 18 healthy men found that GHRH and a synthetic ghrelin receptor hexapeptide given together released more growth hormone than either alone.

Sermorelin itself was approved as Geref in 1990 for diagnosis and in 1997 for treating growth hormone deficiency in children. The sponsor discontinued it in 2008, and FDA later determined the withdrawal was not for reasons of safety or effectiveness. Its adult evidence is small: in a 5 month trial in 19 adults aged 55 to 71, nightly sermorelin raised nocturnal growth hormone and IGF-1 and increased skin thickness, with lean mass and insulin sensitivity gains in men only. [1] [2] [4] [8]

Has the sermorelin and ipamorelin blend been studied?

No published study has tested sermorelin with ipamorelin.

The 1990 synergy study used GHRH and a different ghrelin receptor peptide in single intravenous doses. It did not use ipamorelin, repeated dosing, or any outcome other than growth hormone levels over about an hour.

One small human pharmacology study showed a single IV infusion of ipamorelin releases growth hormone in healthy men; its only randomized trial (postoperative ileus) was negative; no human trial measured body composition or muscle. [1] [6] [12]

What each ingredient has shown alone

• Sermorelin (human RCT evidence). Formerly FDA approved piece of growth hormone releasing hormone (Geref, withdrawn 2009 for business reasons); small trials show higher GH and IGF-1.
• Ipamorelin (animal-only evidence). Growth hormone releaser acting on the hunger hormone (ghrelin) receptor; raised GH in animals and one small study in men; its only randomized trial failed.

Sermorelin and ipamorelin results and before and after claims

No study has measured muscle, fat, sleep, or recovery outcomes with the pair. The measured sermorelin results are modest: in 19 older adults, higher nocturnal growth hormone and IGF-1, thicker skin, and, in men only, more lean mass and better insulin sensitivity, with no change in sleep quality.

Sermorelin before and after claims that go beyond those findings are untested, and adding ipamorelin has no measured effect in people.

A 2026 review of growth hormone axis peptides used outside medical care describes the uncertainty created by stacking in unregulated supply and the lack of evidence for claimed body recomposition benefits. [2] [7]

What are the side effects of the sermorelin and ipamorelin blend?

Sermorelin trials reported injection site pain and redness, flushing, headache, and dizziness, transient hyperlipidemia in the adult trial, and rising fasting glucose and insulin in children. Antibodies to sermorelin were reported in the pediatric program without apparent loss of effect.

Ipamorelin adds increased appetite, flushing, and headache reported anecdotally, and FDA cited immunogenicity risk from impurities in its Category 2 evaluation. Two growth hormone stimulants together could add up glucose and fluid effects; no study has checked.

A 2026 review of growth hormone axis peptides lists fluid retention, joint and muscle pain, appetite changes, and blood glucose problems among reported adverse effects of this class, and flags unproven concerns about growth-promoting effects. [2] [4] [7] [9]

Reported for each ingredient

From each peptide's record. These were reported for the peptide alone, not for the blend. Absence of data is not evidence of safety.

Is the sermorelin and ipamorelin blend legal?

A blend inherits the strictest status among its ingredients, because a mixed product is only as lawful as its least lawful component. For the sermorelin and ipamorelin blend that is Ipamorelin: no lawful path. At least one ingredient cannot be lawfully compounded or prescribed, so no licensed pharmacy can lawfully make the mix.

• Sermorelin regulatory timeline (Regulatory status unknown)
• Ipamorelin regulatory timeline (Removed from Category 2 (Apr 2026))

Why blends like this are sold as research chemicals

A drug for human use in the United States has to be FDA approved or lawfully compounded by a licensed pharmacy for a named patient under a prescription. This blend can be neither, so vials sold under its name carry labels such as “for research use only” or “not for human consumption”. That label does not make a product lawful to inject, and it means no one has checked the vial for identity, purity, sterility, or amount. [10]

WADA status

Sermorelin and Ipamorelin are prohibited at all times on the WADA list, so any product containing them is prohibited for athletes subject to anti-doping testing.

State rules: peptide laws by state. All FDA actions: regulatory tracker.

What does the sermorelin and ipamorelin blend cost, and what can a provider lawfully offer?

Sermorelin has no currently approved product. Many 503A pharmacies compound it on the basis of its former approval, and whether that satisfies federal law depends on how a state board and the pharmacy read it, which is why its FDA status is recorded as unsettled.

Ipamorelin has no lawful path: its nominations were withdrawn, it is not on the 503A bulks list, and it is not a component of an approved drug. A vial containing ipamorelin cannot be lawfully compounded, so the blend has no lawful price.

Licensed programs that prescribe compounded sermorelin alone publish their prices; the sermorelin cost page summarizes them. Tesamorelin, a different GHRH analog, is the only one in the catalog with current FDA approval. [8] [9] [10]

• Sermorelin cost by channel
• Ipamorelin cost by channel
• Rules by state
• Verified provider directory

What's actually offered, and what that means for you

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. That does not make the sermorelin and ipamorelin blend lawful. Ipamorelin is not FDA approved and not on the 503A bulks list, so no pharmacy has a lawful basis to compound the mix. [9] [10]

Enforcement is uneven. FDA mostly acts through warning letters to compounders and online sellers, Category 2 safety listings, and import alerts that let it detain shipments, rather than stopping every pharmacy. State pharmacy boards oversee pharmacies day to day, and their rules differ. [9] [13] [14] [15] [16]

What changes for you

• No FDA review of the product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [16]
• Identity, purity, sterility, and dose accuracy can vary from batch to batch. [9]
• Insurance rarely covers it, so you usually pay cash.
• For tested athletes, the sermorelin and ipamorelin blend contains at least one ingredient that is prohibited at all times on the WADA list. [11]

What to check

These checks lower some risks, but they do not make an unlawfully compounded product lawful or safe. Check for:

• A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [16]
• A real evaluation by a licensed prescriber, not just an online form.
• A certificate of analysis for the specific batch.

Compare the ingredients

• Sermorelin vs ipamorelin
• CJC-1295 vs ipamorelin
• Ipamorelin vs GHRP-6
• Ipamorelin vs MK-677 (ibutamoren)
• Sermorelin vs CJC-1295

Blends that share an ingredient

• CJC-1295 and ipamorelin: CJC-1295 and ipamorelin pair a GHRH analog with a ghrelin mimetic to raise growth hormone. The pair is untested, and neither peptide has a lawful path.
• Tesamorelin and ipamorelin: Tesamorelin is FDA approved as Egrifta; ipamorelin has no lawful path. Mixed together they are untested and cannot be lawfully compounded.

Frequently asked questions

From the blog

• Sermorelin vs HGH: mechanism, evidence, and legal status

  Sermorelin signals the pituitary to release growth hormone; HGH (somatropin) is the hormone itself. Only somatropin is FDA approved today, and anti-aging use of either is off-label.

• Tesamorelin vs sermorelin vs ipamorelin: evidence and legality

  Tesamorelin, sermorelin, and ipamorelin compared in one table: mechanism, FDA approval, compounding status, human evidence, and WADA status, with links to each pairwise comparison.

Sources

Numbered citations above point to these primary sources. PubMed entries link to the indexed abstract.